Mr Evan Gattey, DNP, CRNA | |
200 Hawkins Dr, Iowa City, IA 52242-1009 | |
(319) 356-2633 | |
Not Available |
Full Name | Mr Evan Gattey |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 3 Years |
Location | 200 Hawkins Dr, Iowa City, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366104358 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | D166086 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Iowa Hospital & Clinics | Iowa city, IA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
State University Of Iowa | 7618884230 | 1476 |
News Archive
Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.
Cepheid's updated Winter Care Bundle of Xpert molecular diagnostic tests is an essential tool kit in the battle against virulent infections.
Seven years after tobacco companies signed the Master Settlement Agreement prohibiting them from paying for tobacco brand appearances in movies, the number of tobacco brand appearances in PG-13 rated movies has not experienced a statistically significant decrease, according to a study by Dartmouth Medical School researchers.
Antares Pharma, Inc. today announced that the first patient has been dosed in a clinical study evaluating the VIBEX™ MTX product which is being developed for the treatment of rheumatoid arthritis. The clinical study will evaluate several dose strengths of VIBEX MTX delivered with a proprietary autoinjector versus conventional needle and syringe administration by a healthcare professional.
A virus discovered last year in a rare form of skin cancer has also been found in people with the second most common form of skin cancer among Americans, according to researchers at the Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
› Verified 2 days ago
Entity Name | State University Of Iowa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.
Cepheid's updated Winter Care Bundle of Xpert molecular diagnostic tests is an essential tool kit in the battle against virulent infections.
Seven years after tobacco companies signed the Master Settlement Agreement prohibiting them from paying for tobacco brand appearances in movies, the number of tobacco brand appearances in PG-13 rated movies has not experienced a statistically significant decrease, according to a study by Dartmouth Medical School researchers.
Antares Pharma, Inc. today announced that the first patient has been dosed in a clinical study evaluating the VIBEX™ MTX product which is being developed for the treatment of rheumatoid arthritis. The clinical study will evaluate several dose strengths of VIBEX MTX delivered with a proprietary autoinjector versus conventional needle and syringe administration by a healthcare professional.
A virus discovered last year in a rare form of skin cancer has also been found in people with the second most common form of skin cancer among Americans, according to researchers at the Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Evan Gattey, DNP, CRNA 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-2633 | Mr Evan Gattey, DNP, CRNA 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-2633 |
News Archive
Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.
Cepheid's updated Winter Care Bundle of Xpert molecular diagnostic tests is an essential tool kit in the battle against virulent infections.
Seven years after tobacco companies signed the Master Settlement Agreement prohibiting them from paying for tobacco brand appearances in movies, the number of tobacco brand appearances in PG-13 rated movies has not experienced a statistically significant decrease, according to a study by Dartmouth Medical School researchers.
Antares Pharma, Inc. today announced that the first patient has been dosed in a clinical study evaluating the VIBEX™ MTX product which is being developed for the treatment of rheumatoid arthritis. The clinical study will evaluate several dose strengths of VIBEX MTX delivered with a proprietary autoinjector versus conventional needle and syringe administration by a healthcare professional.
A virus discovered last year in a rare form of skin cancer has also been found in people with the second most common form of skin cancer among Americans, according to researchers at the Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
› Verified 2 days ago
Mr. Larry Joseph Pirotte, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 601 Hw 6 W, Va Medical Center, Iowa City, IA 52246 Phone: 319-338-0581 | |
Elizabeth M Giedt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2633 Fax: 319-356-2940 | |
Alex M Hugi, CRNA ARNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2633 Fax: 319-356-2940 | |
Ms. Allison Leigh Aird, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2210 Fax: 319-356-2940 | |
Mrs. Sara Elizabeth Wertz, RN, BSN, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7354 | |
Sarah Cisco, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Dept Of Anesthesia, Iowa City, IA 52242 Phone: 319-356-2633 Fax: 319-356-2940 | |
Mrs. Hayley Anne Smith, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Dept Of Anesthesia, Iowa City, IA 52242 Phone: 319-356-2633 Fax: 319-356-2940 |